COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Mydecine Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting...

Algernon Pharmaceuticals Hits Co-Primary Endpoint in its Phase 2 Study of...

Algernon Pharmaceuticals Hits Co-Primary Endpoint in its Phase 2 Study of...

PT339 – Kim Dudine – Cannabis: The Gateway Drug to Unity...

Psychedelic Investor Pulse Survey Results (Summer 2022)

PT338 – Melissa Lavasani – The Power of Storytelling, The Preservation...

George Tziras to Succeed Peter Rands as Small Pharma Chief...

Small Pharma Reports Fiscal First Quarter 2023 Highlights

FILAMENT HEALTH ANNOUNCES CLOSING OF $2,500,080 PRIVATE PLACEMENT

Load more